Does TOCILIZUMAB Cause Obesity? 1,630 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,630 reports of Obesity have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 1.7% of all adverse event reports for TOCILIZUMAB.
1,630
Reports of Obesity with TOCILIZUMAB
1.7%
of all TOCILIZUMAB reports
990
Deaths
1,426
Hospitalizations
How Dangerous Is Obesity From TOCILIZUMAB?
Of the 1,630 reports, 990 (60.7%) resulted in death, 1,426 (87.5%) required hospitalization, and 1,012 (62.1%) were considered life-threatening.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 1,630 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
RITUXIMAB (1,392)
Which TOCILIZUMAB Alternatives Have Lower Obesity Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE